semaglutide stop production The Ozempic Shortage Is Over

The FDA's Decision to Ban Compounds: What You Need to Know

28.41

★★★★☆4.8 (126)

Novo Nordisk's semaglutide shortage officially concludes in the US, spelling major threat for weight loss drug compounders

29.87

★★★★★4.9 (98)

The era of $199 copycat weight loss drugs is ending — and it could cost patients

24.08

★★★★★5.0 (157)

The FDA has removed semaglutide injection products (GLP-1) from the shortage list, ending the temporary rule that allowed pharmacies to compound these medications, often used for weight loss. Compounded drugs are custom-made

27.11

★★★★★4.7 (84)

Nevada recently announced a major regulatory change: Compounding semaglutide and tirzepatide injections is now prohibited—even in salt forms like semaglutide sodium. This impacts 503A pharmacies and 503B outsourcing facilities across the state,

23.45

★★★★★4.9 (203)

The FDA has removed semaglutide injection products (GLP-1) from the shortage list, ending the temporary rule that allowed pharmacies to compound these medications, often used for weight loss. Compounded drugs are custom-made

25.25

★★★★★5.0 (176)

Millions using weight-loss drug copycats despite being riskier

28.73

★★★★★4.8 (132)